Rankings
Pricing
Log In
Free Trial
US-listed companies
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.
NVCT
Market cap
$108.39M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2022
Dec 31,
2023
Cash and cash equivalents
20
19
Other current assets
0
0
TOTAL CURRENT ASSETS
20
19
TOTAL ASSETS
20
19
TOTAL ASSETS
20
19
Accounts payables
3
3
Accounts payables
3
3
Payable offering costs
0
-
Accrued liabilities
0
0
Employee compensation and benefits
2
4
TOTAL CURRENT LIABILITIES
6
7
Payable offering costs
0
-
TOTAL LIABILITIES
6
7
Accrued liabilities
0
0
Employee compensation and benefits
2
4
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL CURRENT LIABILITIES
6
7
TOTAL LIABILITIES
6
7
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
Cash and cash equivalents
20
19
Other current assets
0
0
TOTAL CURRENT ASSETS
20
19
TOTAL ASSETS
20
19
TOTAL ASSETS
20
19
Accounts payables
3
3
Accounts payables
3
3
Payable offering costs
0
-
Accrued liabilities
0
0
Employee compensation and benefits
2
4
TOTAL CURRENT LIABILITIES
6
7
Payable offering costs
0
-
TOTAL LIABILITIES
6
7
Accrued liabilities
0
0
Employee compensation and benefits
2
4
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL CURRENT LIABILITIES
6
7
TOTAL LIABILITIES
6
7
Additional paid in capital
46
66
Accumulated deficit
-32
-54
Additional paid in capital
46
66
TOTAL SHAREHOLDERS' EQUITY
14
12
Accumulated deficit
-32
-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19
TOTAL SHAREHOLDERS' EQUITY
14
12
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
20
19